CStone Pharmaceuticals Revenue

CStone Pharmaceuticals had revenue of 49.45M CNY in the half year ending June 30, 2025, a decrease of -81.09%. This brings the company's revenue in the last twelve months to 202.49M, down -55.65% year-over-year. In the year 2024, CStone Pharmaceuticals had annual revenue of 407.21M, down -12.21%.

Revenue (ttm)

202.49M CNY

Revenue Growth

-55.65%

P/S Ratio

43.00

Revenue / Employee

1.55M CNY

Employees

131

Market Cap

9.54B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	407.21M	-56.64M	-12.21%
Dec 31, 2023	463.84M	-17.52M	-3.64%
Dec 31, 2022	481.36M	237.65M	97.51%
Dec 31, 2021	243.72M	-795.11M	-76.54%
Dec 31, 2020	1.04B	-	-
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shanghai Haohai Biological Technology	2.75B
HBM Holdings	908.35M
Abbisko Cayman	681.17M
Lepu Biopharma	767.54M
Alphamab Oncology	861.24M
CK Life Sciences Int'l., (Holdings)	5.49B
Everest Medicines	932.82M
Ascletis Pharma	2.59M

Revenue Rankings

CStone Pharmaceuticals News

14 days ago - CStone Secures MHRA Approval For Sugemalimab In Stage III NSCLC In UK - Nasdaq
15 days ago - CStone Announces MHRA Approval in UK for Sugemalimab in Stage III NSCLC - PRNewsWire

More News